Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

OPTN

OptiNose (OPTN)

OptiNose Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:OPTN
DateTimeSourceHeadlineSymbolCompany
08/02/202503:58Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:OPTNOptiNose Inc
15/01/202523:52Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OPTNOptiNose Inc
15/01/202523:00GlobeNewswire Inc.Optinose Announces Preliminary Unaudited Fourth Quarter 2024 XHANCE Net Revenue of $22.4 MillionNASDAQ:OPTNOptiNose Inc
31/12/202408:32Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OPTNOptiNose Inc
26/12/202423:00GlobeNewswire Inc.Optinose Announces 1-for-15 Reverse Stock SplitNASDAQ:OPTNOptiNose Inc
24/12/202401:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OPTNOptiNose Inc
19/12/202408:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPTNOptiNose Inc
19/12/202408:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPTNOptiNose Inc
18/12/202401:10Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:OPTNOptiNose Inc
18/12/202401:05Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:OPTNOptiNose Inc
13/12/202402:04Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:OPTNOptiNose Inc
03/12/202408:05Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:OPTNOptiNose Inc
03/12/202407:53GlobeNewswire Inc.Optinose to Present at the Piper Sandler 36th Annual Healthcare ConferenceNASDAQ:OPTNOptiNose Inc
28/11/202408:16Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:OPTNOptiNose Inc
13/11/202400:02Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OPTNOptiNose Inc
12/11/202423:24Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OPTNOptiNose Inc
12/11/202423:00GlobeNewswire Inc.Optinose Reports Third Quarter 2024 Financial Results and Recent Operational HighlightsNASDAQ:OPTNOptiNose Inc
06/11/202408:30GlobeNewswire Inc.Optinose Announces Reporting Date for Third Quarter 2024 Financial ResultsNASDAQ:OPTNOptiNose Inc
19/10/202405:52Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:OPTNOptiNose Inc
17/10/202408:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OPTNOptiNose Inc
17/10/202407:05GlobeNewswire Inc.Optinose Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:OPTNOptiNose Inc
08/10/202409:40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPTNOptiNose Inc
08/10/202409:39Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:OPTNOptiNose Inc
08/10/202407:59GlobeNewswire Inc.Optinose Appoints Terry Kohler as Chief Financial OfficerNASDAQ:OPTNOptiNose Inc
26/09/202406:33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OPTNOptiNose Inc
19/09/202406:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPTNOptiNose Inc
19/09/202406:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPTNOptiNose Inc
17/09/202410:37Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:OPTNOptiNose Inc
17/09/202410:36Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:OPTNOptiNose Inc
05/09/202423:00GlobeNewswire Inc.New Peer-Reviewed Data Highlight the Benefits of XHANCE in Chronic Rhinosinusitis Patients with or without Prior Sinus SurgeryNASDAQ:OPTNOptiNose Inc
 Showing the most relevant articles for your search:NASDAQ:OPTN